Abstract

ADVERTISEMENT RETURN TO ISSUEPREVViewpointNEXTMavyret: A Pan-Genotypic Combination Therapy for the Treatment of Hepatitis C InfectionPublished as part of the Biochemistry series “Biochemistry to Bedside”Ashley N. Matthew, Nese Kurt Yilmaz, and Celia A. Schiffer*View Author Information Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01605, United States*Phone: +1 508 856 8008. Fax: +1 508 856 6464. E-mail: [email protected]Cite this: Biochemistry 2018, 57, 5, 481–482Publication Date (Web):December 1, 2017Publication History Received15 November 2017Published online1 December 2017Published inissue 6 February 2018https://doi.org/10.1021/acs.biochem.7b01160Copyright © 2017 American Chemical SocietyRIGHTS & PERMISSIONSArticle Views2948Altmetric-Citations8LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InReddit PDF (384 KB) Get e-AlertsSUBJECTS:Combination therapy,Genetics,Infectious diseases,Inhibitors,Peptides and proteins Get e-Alerts

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call